This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Healthy Volunteers
and you are
between 18 and 65
years old
The primary goal of this phase is to monitor the long-term effects.
The treatment is already on the market.
Show me locations

The purpose

The purpose of this study is to compare the effect of intravenous ropivacaine and lidocaine on the receptive field of primary sensory afferents and their influence on the vascular bed. *Trial with medicinal product

Provided treatments

  • Drug: ropivacaine (Naropin)
Tris trial is registered with FDA with number: NCT00900913. The sponsor of the trial is University of Zurich and it is looking for 34 volunteers for the current phase.
Official trial title:
Effect of Systemic Ropivacaine on Hyperalgesia, Flare Reaction and Peripheral